Jun-Yan LiuFei LiaoGuo-jun ChenBin WangYefei TianChengzhi ChenJie XiaKai-Fu TangYong-Hong ZhangHui ZhouWei ChengXinyi MuTao TanFeng YangFei-Fei ShangKai WangZheng PanQuanxin LongQiang TangYou-xue LiuYang BiJun-hao JiangYan SunLiangke ZhangTingting WangKe YangWan DongDing'an ZhouNi TangJing LiJun ZhangJun ZhaoLing LiGui-Qiong HeZijun ChenLixue ChenMengliang YeYuan Hu
P108
Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary DysplasiaA Research in Pharmacogenomics and Accurate Medication of Novel Oral AnticoagulantsA Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/mlLong-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic ArthritisChina Cognition and Aging StudyHuman Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary DysplasiaA Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate CancerA Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung CancerSelective High Frequency Oscillatory Ventilation (HFOV) for NeonatesA Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian CancerA Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous NSCLCThe Chinese Familial Alzheimer's NetworkA Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before TransplantationA Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Trial of Maintenance Treatment With BGB-290 Versus Placebo in Patients With Platinum-sensitive Recurrent Ovarian CancerA Study Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer.Invasive Ventilation for Neonates With Acute Respiratory Distress Syndrome(ARDS)Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular EventsA Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding BiomarkersA Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene AberrationsA Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic ArthritisA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic ArthritisA Study of Apalutamide in Participants With High‑Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyA Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIASafety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate CancerStudy of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial CarcinomaA Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast CancerHuman Mesenchymal Stem Cells For Bronchopulmonary DysplasiaStudy of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation
P6153
Q42322505-8BDCEC0E-A800-410A-92DC-B43EEB690A41Q42790279-4AD2FB63-DBBB-4579-AE52-13D159AD3CD9Q43183546-0597E165-68D8-493D-B206-5D01B43BF20CQ47373629-73642C4D-7EF5-4BBD-AFDF-C4DD82795485Q51692579-970E90DC-B72C-4312-85AD-BCC3B8B8046AQ56994609-D86512A3-1633-4202-B071-DBCBA75A3C77Q57054014-bf846a4e-419f-f5d5-013a-c703e696906cQ57250418-FE2C8C59-3CE5-49B6-8E3E-70BE9322EEE6Q57413808-41E360D2-63AD-4437-929C-DF386F4423E5Q57767407-FDE403DB-8CF2-4081-AA46-101680E0B3D5Q59429566-CAAED319-6D1F-452D-B471-EEC6B74FB08FQ59705313-1012BC3F-C0CC-4F61-9B24-D5E6ADB03945Q60596198-2BB9EED5-0457-4E0D-B7E1-487CCF0483E5Q60724095-D26D8594-401A-4067-B2B9-F4700DEC29ABQ60724095-F866ADEC-F8AA-473E-BD3E-A29CE700F245Q61022648-57C5AB10-00C8-4FCB-BA93-A602DF1970A1Q61111112-F8D78396-7E0F-4697-B940-636A1FE1F7D3Q61472490-7A03866A-3A52-45F6-9AC1-9F6CBAE23DE8Q64820008-6078251C-1F49-491D-ADB8-1DB7D52503F3Q79270279-594B2C14-542F-4F6B-9AF7-AB7B2D8C2595Q81013505-D77CDC98-6123-4242-93F2-ADD8388F36A5Q84138041-D62AFBF5-5984-495F-A0AA-067B8E64CCEAQ84308604-7F5DA792-2A63-459D-892A-6D6C51DE73CDQ84957254-1D729FEB-7933-4594-A9F3-A6E1CE5DC605Q85638610-A209F566-42F7-46E2-845B-517940814E48Q87651527-AD22B4B5-FD2C-4B54-9C90-B8DC391584EFQ87656435-EFA6D3BB-2017-4917-880C-E0737BBBD96BQ87666316-6FA90F26-AC87-415B-817E-A69FA457BAAFQ87769446-73C4399E-ACFF-4BE1-B6BC-9812E9FCCA88Q87796982-B672634E-67F1-49FC-BF2C-07C3EE2820F4Q88033907-763395D0-38E6-4DB8-BB6E-3B7FCCA16CAEQ88357745-FAAE6F98-AA33-4DBA-86A3-6F2421CCD28BQ88498034-48C5AEFE-518C-4E3A-85FC-B9BCB62438BFQ88686675-21049609-C13C-415E-A78E-EC2140815029Q88991920-62BA2F35-50A5-41ED-BCD6-7680FD2074EFQ89208494-A1792B5A-60FB-4CF8-9654-D0B6EF33A92FQ89297714-CD0C7C58-65F8-4F5A-B609-0F533584CD8CQ89579019-E941A490-1842-4A81-BA82-28BA8BAECD8DQ89708510-639AE2E2-0525-450B-8C8B-CECABA3CB589
P108
Q61907629-63AD7328-3DC0-4DBB-AE5B-13FE353902D4Q61909193-4FFF37A6-5FBC-419E-9057-56F811DA4A31Q61956771-7F2A6836-9DC7-4FA9-8E9F-67DD36C3A003Q61957709-175A2551-05E8-4CAE-80D2-B2A5454DE28CQ62025186-B32F3842-8C24-4BAA-B562-B1DE3F37F63FQ62030961-5AD2887E-D355-4FFC-8936-2373CC8D7339Q62034171-224AC542-29C3-4EA4-8E85-FE05BCCE138BQ62034516-5E472EAE-FC0B-4D97-A2DD-23DF60D2029EQ62035468-2B571B02-DE20-4EB3-B337-298DD4A06260Q62042285-824FF007-E9D5-476C-9EBD-B589AE88B876Q62062171-DAC4C948-169E-4A1E-9BE2-B898BDE1E039Q62062596-631A5C63-2BD6-40E5-8D27-0838CEB88886Q62814527-0A519196-F49F-402A-9D15-F3B79D1A6917Q62816973-2A5400C7-DD4E-4F60-91A4-5F4C99D168BDQ63394796-5617000A-C9C2-442F-8BB1-641E6FEA9CDEQ63395178-7CE3D040-A008-42BE-8CE3-C27F75343046Q63397328-A452EA84-8735-429C-9BA4-3855A486A7D9Q63397758-D7B51132-247A-49BA-A351-03E0958D2681Q63405227-A4E86AF9-1F7E-400E-AB00-875D7136FF7CQ63572938-C8EEEE24-C480-446A-B02A-7E7B2F2E3D3EQ63572946-632B1681-51A7-49DF-AE66-24D27DF1F706Q63572977-231C8DD4-2CF4-4263-8134-9C656779BA1BQ63574006-8AD26A43-03F5-4605-9C0F-5D3F3EFB8EF3Q63575010-7177055C-820D-4287-87F5-C1DC4EC9F739Q63577765-8FFFFEA1-5ECF-47F2-9D5E-1535155A2090Q64139366-840FA220-6171-44D5-B99A-AD58518E23A1Q64150519-35DF7CBF-FC94-4DF3-9591-F7A96A3AA256Q64151534-64611674-4EC4-4AD8-AE0F-4B1F5D100AB6Q64151537-70EBFE46-8731-4400-ACF8-D2A33AA6E6D2Q64172697-46089FF0-D9B1-40BD-988D-F8CE73BF09A3
P6153
description
1956年创建的一所学校
@zh
Universität in der Volksrepublik China
@de
universitas di Republik Rakyat Tiongkok
@id
universiteit in Chongqing, Volksrepubliek China
@nl
جامعة في تشونغتشينغ، الصين
@ar
name
Chongqing Medical University
@en
Chongqing Medical University
@en-ca
Chongqing Medical University
@en-gb
Prifysgol Meddygol Chongqing
@cy
重庆医科大学
@zh
type
label
Chongqing Medical University
@en
Chongqing Medical University
@en-ca
Chongqing Medical University
@en-gb
Prifysgol Meddygol Chongqing
@cy
重庆医科大学
@zh
altLabel
Chongqing University of Medical Sciences
@en
prefLabel
Chongqing Medical University
@en
Chongqing Medical University
@en-ca
Chongqing Medical University
@en-gb
Prifysgol Meddygol Chongqing
@cy
重庆医科大学
@zh
P214
P244
P3153
P6366
P646
P131
P213
0000 0000 8653 0555
P214
P2427
grid.203458.8
P244
P3153
501100004374
P3417
Chongqing-Medical-University-1
P3500
P373
Chongqing Medical University
P5242
Chongqing-Medical-University
P5600
chongqing-medical-university
P571
1956-01-01T00:00:00Z
P625
Point (106.505 29.53583333)